REFERENCES
- Levin L., Hryniuk W. M. Dose Intensity Analysis of Chemotherapy Regimens in Ovarian Carcinoma. J. Clin. Oncol. 1987; 5: 756–767
- Edmonson J. H., Hartmann L. C., Long H. J., Colon-Otero G., Fitch T. R., Jefferies J. A., Braich T. A., Maples W. J. Granulocyte-Macrophage Colony-Stimulating Factor: Preliminary Observations on the Influences of Dose, Schedule, and Route of Administration in Patients Receiving Cyclophosphamide and Carboplatin. Cancer 1992; 70: 2529–2539
- Calvert A. H., Newell D. R., Gumbrell L. A., O'Reilly S., Burnell M., Boxall F. E., Siddik Z. H., Judson I. R., Gore M. E., Wiltshaw E. Carboplatin Dosage: Prospective Evaluation of a Simple Formula Based on Renal Function. J. Clin. Oncol. 1989; 7: 1748–1756
- McGuire W. P., Hoskins W. J., Brady M. F., Kucera P. R., Look K. Y., Partridge E. E., Davidson M. A Phase III Trial Comparing Cisplatin/Cytotoxan (PC) and Cisplatin/ Taxol (PT) in Advanced Ovarian Cancer. Proc. Am. Soc. Clin. Oncol. 1993; 12: 255
- Thigpen J. T. Dose Intensity in Ovarian Carcinoma: Hold, Enough?. J Clin. Oncol. 1997; 15: 1291–1293
- Legros M., Dauplat J., Fleury J., Cure H., Suzanne F., Chassagne J., Bay J. O., Sol C., Canis M., Condat P., Choufi B., Tavernier F., Glenat C., Chollet P., Plagne R. High-Dose Chemotherapy with Hematopoietic Rescue in Patients with Stage III to IV Ovarian Cancer: Long-Term Results. J. Clin. Oncol. 1997; 15: 1302–1308
- Stiff P. J., Bayer R., Kerger C., Potkul R. K., Malhotra D., Peace D. J., Smith D., Fisher S. G. High-Dose Chemotherapy with Autologous Transplantation for Persistent/ Relapsed Ovarian Cancer: A Multivariate Analysis of Survival for 100 Consecutively Treated Patients. J. Clin. Oncol. 1997; 15: 1309–1317